| Abstract: | Datamonitor's Tongli Pharmaceuticals (USA), Inc. Company Profile is the essential source for top-level company data and information. Tongli Pharmaceuticals (USA), Inc. Company Profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Tongli Pharmaceuticals (TP), through its wholly-owned subsidiary, Harbin Tianmu Pharmaceuticals Co., develops, produces and sells a variety of pharmaceuticals and healthcare products in the People's Republic of China that are based on traditional Chinese medicine, or traditional Chinese medicine (TCM). The company primarily operates in the US where it is headquartered in New York and employs around 86 people. The company recorded revenues of $7.4 million in the fiscal year ended March 2009, as compared to the revenues of $2 million in 2008. The company's operating profit was $2.1 million in fiscal 2009, as compared to an operating profit of $0.4 million in 2008. Its net profit was $1.9 million in fiscal 2009, as compared to the net profit of $0.3 million in 2008.
Scope of the Report
- Provides all the crucial information on Tongli Pharmaceuticals (USA), Inc. required for business and competitor intelligence needs -Data is supplemented with details on Tongli Pharmaceuticals (USA), Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Tongli Pharmaceuticals (USA), Inc.
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better - Qualify prospective partners and suppliers - Keep fully up to date on your competitors' business structure, strategy and prospects - Obtain the most up to date company information available
|
| Brief Excerpt: | ...Tongli Pharmaceuticals (TP), through its wholly-owned subsidiary, Harbin Tianmu Pharmaceuticals Co., develops, produces and sells a variety of pharmaceuticals and healthcare products in the People's Republic of China that are based on traditional Chinese medicine, or traditional Chinese medicine (TCM). The company primarily operates in the US where it is headquartered in New York and employs around 86 people. The company recorded revenues of $7.4 million in the fiscal year ended March 2009, as compared to the revenues of $2 million in 2008. The company's operating profit was $2.1 million in fiscal 2009, as compared to an operating profit of $0.4 million in 2008. Its net profit was $1.9 million in fiscal 2009, as compared to the net profit of $0.3 million in 2008....
|